How psychedelics could deliver antidepressant benefits without hallucinogenic effects

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

Could psychedelics become a new generation of treatments for depression and other psychiatric disorders? This question is no longer confined to basic research. Several therapies based on classical psychedelics have advanced into late-stage clinical development and have reported encouraging results. DT120, an LSD-based candidate, and COMP360, a synthetic psilocybin formulation, have both received…

Read original article on Medical Xpress - latest medical and health news stories →

Related news